- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (17)
7 result(s) found for: Diaper.
Displaying page 1 of 1.
EudraCT Number: 2012-003567-22 | Sponsor Protocol Number: Zincox12 | Start Date*: 2012-12-05 | |||||||||||
Sponsor Name:A.O. UNIVERSITARIA INTEGRATA DI VERONA | |||||||||||||
Full Title: Efficacy of topical application of zinc oxide ointment compared with zinc oxide paste and tocoferol, for treating diaper dermatitis in infant: a randomized, controlled, triple blind study | |||||||||||||
Medical condition: Diaper dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001184-29 | Sponsor Protocol Number: IMA-GER-0601 | Start Date*: 2006-07-06 |
Sponsor Name:Spirig Pharma AG | ||
Full Title: A controlled, randomized, evaluator-blinded study for the assessment of efficacy and safety of ImazolĀ® Paste and MultilindĀ® Heilsalbe in infants with diaper dermatitis | ||
Medical condition: Diaper dermatitis (diaper rash) | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003144-50 | Sponsor Protocol Number: V00400GL2011A | Start Date*: 2011-11-03 | |||||||||||
Sponsor Name:Pierre Fabre Dermatologie, Represented by Institut de Recherche Pierre Fabre | |||||||||||||
Full Title: A randomised, double blind, controlled, multicentre study in infants with infantile hemangioma to compare propranolol gel to placebo | |||||||||||||
Medical condition: Proliferating localised uncomplicated infantile hemangioma not requiring systemic therapy | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002396-35 | Sponsor Protocol Number: XPF-009-301 | Start Date*: 2021-11-15 | |||||||||||
Sponsor Name:Xenon Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3 Study of Adjunctive XEN496 in Pediatric Subjects with KCNQ2 Developmental and Epileptic Encephalopathy | |||||||||||||
Medical condition: KCNQ2 Developmental and Epileptic Encephalopathy | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) ES (Prematurely Ended) FR (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003221-22 | Sponsor Protocol Number: TAK-555-3010 | Start Date*: 2024-01-15 |
Sponsor Name:Takeda Development Center Americas, Inc. | ||
Full Title: Phase 3, Multicenter, Randomized Study With 2 Different Doses of Prucalopride Administered to Male and Female Pediatric Subjects Aged 6 Months to 17 Years With Functional Constipation, Consisting o... | ||
Medical condition: Constipation | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2020-006051-17 | Sponsor Protocol Number: mRNA-1647-P301 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:ModernaTX, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Year... | |||||||||||||
Medical condition: Prevention of Cytomegalovirus infection | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing) EE (Trial now transitioned) FI (Trial now transitioned) IT (Trial now transitioned) FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013262-84 | Sponsor Protocol Number: V00400SB201 | Start Date*: 2009-10-28 | |||||||||||
Sponsor Name:PIERRE FABRE DERMATOLOGIE | |||||||||||||
Full Title: A randomised, controlled, multidose, multicentre, adaptive phase II/III study in infants with proliferating infantile hemangiomas requiring systemic therapy to compare four regimens of propranolol ... | |||||||||||||
Medical condition: Proliferating Infantile Hemangioma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) ES (Completed) IT (Completed) HU (Completed) LT (Completed) CZ (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
